Open AccessNomogram to predict dermatomyositis prognosis: a population-based study of 457 cases
Author(s) -
Yimin Li,
Yuhui Li,
Yuguang Wang,
Lianjie Shi,
Fu-An Lin,
Zongxue Zhang,
Jingli Zhang,
Fangjingwei Xu,
Xiaolin Sun
Publication year - 2022
Publication title -
clinical and experimental rheumatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.184
H-Index - 95
eISSN - 1593-098X
pISSN - 0392-856X
DOI - 10.55563/clinexprheumatol/0ddt88
Subject(s) - medicine , nomogram , proportional hazards model , cohort , oncology , dermatomyositis
Dermatomyositis (DM) is a systemic autoimmune disease, which typically affects the striated muscle with a variable involvement of the skin and other organs. Clinically amyopathic DM (CADM) is a combination of hypomyopathic DM (HDM) and amyopathic DM (ADM), with a characteristic of skin-predominant lesions. To date, large-scale studies on the prognostic factors of DM/CADM have been limited. The aim of this study is to evaluate the prognostic values of clinical manifestations in DM/CADM and to develop a prognostic nomogram for DM/CADM.